Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2022-04-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 8th Board of Directors 8th meeting of Jiuzhitang Co., Ltd. It includes voting results on various reports and proposals such as the 2021 Board report, 2021 annual report and summary, 2021 financial statements, internal control self-evaluation report, social responsibility report, profit distribution plan, appointment of audit firm, financing proposals, senior management remuneration, nomination of independent directors, amendments to company articles of association, shareholder meeting rules, board meeting rules, and secretary work system. It also announces the date for the 2021 Annual General Meeting (AGM) and specifies which items will be submitted to the AGM for approval. The document is primarily about board meeting resolutions and governance matters, including management and board structure changes, and procedural rules. It does not contain the full annual report or financial statements but references them as published elsewhere. Therefore, this document is best classified as Board/Management Information (MANG) because it announces board meeting decisions, management proposals, and governance changes rather than the full annual report or other filings.
2022-04-22 Chinese
股东大会议事规则（草案）
Governance Information Classification · 95% confidence The document is titled as "九芝堂股份有限公司股东大会议事规则（草案）" which translates to "Rules of Procedure for the Shareholders' General Meeting (Draft)" of the company 九芝堂股份有限公司. The content extensively details the rules, procedures, and regulations governing the conduct of shareholders' meetings, including the convening, proposal submission, voting procedures, and other governance-related matters. There is no financial data, earnings information, or report publication announcement. It is not a notice of voting results or a proxy solicitation but rather a governance document outlining internal rules for shareholder meetings. Therefore, the document fits best under Governance Information (CGR). The document length (6904 characters) and detailed procedural content support this classification with high confidence.
2022-04-22 Chinese
第八届监事会第七次会议监事书面审核意见
Regulatory Filings Classification · 95% confidence The document is a written supervisory board review opinion on the company's 2021 annual report, 2021 internal control self-evaluation report, and 2022 first quarter report. It contains no actual financial data or detailed financial statements but rather opinions on the reports' preparation and compliance with regulations. The document length is short (738 characters), and it serves as an attestation or certification by the supervisory board rather than the reports themselves. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or Interim Report (IR).
2022-04-22 Chinese
2021年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the "2021年度财务决算报告" which translates to "2021 Annual Financial Settlement Report". It contains detailed financial data for the full year 2021, including audited financial statements, income statement, balance sheet, cash flow analysis, and notes on accounting policies. The report mentions an independent auditor's unqualified opinion and provides comprehensive financial metrics and analysis for the fiscal year ending December 31, 2021. The length of the document (6798 characters) and the presence of substantive financial data confirm it is a full annual financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2021
2022-04-22 Chinese
证券投资专项说明
Regulatory Filings Classification · 95% confidence The document is a special statement from the board of directors regarding the company's securities investment situation for the year 2021. It details the approval process, investment purpose, funding source, investment scope, investment results, internal control execution, and impact on the company. The document is relatively short (782 characters) and focuses on a specific topic related to securities investment by the company, not a full financial report or earnings release. It is not an announcement of voting results, management changes, or legal proceedings. It is a regulatory disclosure about securities investment activities, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Annual Report, Earnings Release, or Capital/Financing Update. Therefore, the classification is RNS with high confidence.
2022-04-22 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2021 by 九芝堂股份有限公司. It discusses the company's internal control evaluation, including financial and non-financial control defect standards, evaluation scope, and conclusions about the effectiveness of internal controls. The document is a detailed report on internal control evaluation rather than an announcement or a brief summary. It does not fit the definitions of Annual Report (10-K), Audit Report (AR), or other categories like Earnings Release or Management Reports. The content aligns with an Audit Report / Information (AR) as it focuses on internal control evaluation, defect identification, and compliance with regulatory internal control standards. The document length is 3140 characters, which is relatively short but contains substantive evaluation content, not just an announcement or certification. Therefore, the best classification is AR (Audit Report / Information). FY 2021
2022-04-22 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.